Reply: Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial

No AccessJournal of UrologyReply to Letters to the Editor12 Aug 2024Reply: Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trialis accompanied byComparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trialis a reply to letterLetter: Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial Clinton D. Bahler Clinton D. BahlerClinton D. Bahler Corresponding Author: Clinton D. Bahler, MD, MS, Department of Urology, Indiana University, 535 N Barnhill Dr, Suite 420 Indiana Cancer Pavilion, Indianapolis, IN 46202 ([email protected]) View All Author Informationhttps://doi.org/10.1097/JU.0000000000004170AboutFull TextPDF Cite Export CitationSelect Citation formatNLMAMAIEEEACMAPAChicagoMLAHarvardTips on citation downloadDownload citationCopy citation ToolsAdd to favoritesTrack Citations ShareFacebookLinked InTwitterEmail "Reply: Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. Comparing magnetic resonance imaging and prostate-specific membrane antigen–positron emission tomography for prediction of extraprostatic extension of prostate cancer and surgical guidance: a prospective nonrandomized clinical trial. J Urol.2024; 212(2):290-298. doi: 101097JU0000000000004032 Link, Google Scholar 2. . A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI. Radiology.2019; 290(3):709-719. doi: 10.1148/radiol.2018181278 Crossref, Medline, Google Scholar Recusal: Dr Bernie, early career editor of The Journal of Urology®, was recused from the editorial and peer review processes due to affiliation with Indiana University. Funding/Support: None. Conflict of Interest Disclosures: The Author has no conflicts of interest to disclose. Ethics Statement: Institutional Review Board approval was not required because this paper is based on publicly available databases. Author Contributions: Conception and design: Bahler. Data acquisition: Bahler. Data analysis and interpretation: Bahler. Drafting the manuscript: Bahler. Critical revision of the manuscript for scientific and factual content: Bahler. Statistical analysis: Bahler. Supervision: Bahler. © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology24 May 2024Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical TrialJournal of Urology25 Jul 2024Letter: Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen–Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Clinton D. Bahler Corresponding Author: Clinton D. Bahler, MD, MS, Department of Urology, Indiana University, 535 N Barnhill Dr, Suite 420 Indiana Cancer Pavilion, Indianapolis, IN 46202 ([email protected]) More articles by this author Expand All Recusal: Dr Bernie, early career editor of The Journal of Urology®, was recused from the editorial and peer review processes due to affiliation with Indiana University. Funding/Support: None. Conflict of Interest Disclosures: The Author has no conflicts of interest to disclose. Ethics Statement: Institutional Review Board approval was not required because this paper is based on publicly available databases. Author Contributions: Conception and design: Bahler. Data acquisition: Bahler. Data analysis and interpretation: Bahler. Drafting the manuscript: Bahler. Critical revision of the manuscript for scientific and factual content: Bahler. Statistical analysis: Bahler. Supervision: Bahler. Advertisement PDF downloadLoading ...